- Home
- AVD vs MIST Comparison
AVD vs MIST Comparison
Compare AVD & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVD
- MIST
- Stock Information
- Founded
- AVD 1969
- MIST 2003
- Country
- AVD United States
- MIST Canada
- Employees
- AVD N/A
- MIST N/A
- Industry
- AVD Agricultural Chemicals
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- AVD Industrials
- MIST Health Care
- Exchange
- AVD Nasdaq
- MIST Nasdaq
- Market Cap
- AVD 158.9M
- MIST 145.3M
- IPO Year
- AVD N/A
- MIST N/A
- Fundamental
- Price
- AVD $5.61
- MIST $1.96
- Analyst Decision
- AVD Strong Buy
- MIST Strong Buy
- Analyst Count
- AVD 1
- MIST 3
- Target Price
- AVD $12.00
- MIST $6.33
- AVG Volume (30 Days)
- AVD 165.0K
- MIST 1.2M
- Earning Date
- AVD 11-10-2025
- MIST 11-11-2025
- Dividend Yield
- AVD N/A
- MIST N/A
- EPS Growth
- AVD N/A
- MIST N/A
- EPS
- AVD N/A
- MIST N/A
- Revenue
- AVD $529,067,000.00
- MIST N/A
- Revenue This Year
- AVD N/A
- MIST N/A
- Revenue Next Year
- AVD $3.54
- MIST N/A
- P/E Ratio
- AVD N/A
- MIST N/A
- Revenue Growth
- AVD N/A
- MIST N/A
- 52 Week Low
- AVD $3.28
- MIST $0.63
- 52 Week High
- AVD $6.68
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- AVD 62.42
- MIST 66.84
- Support Level
- AVD $5.24
- MIST $1.75
- Resistance Level
- AVD $5.84
- MIST $1.83
- Average True Range (ATR)
- AVD 0.25
- MIST 0.09
- MACD
- AVD -0.03
- MIST 0.01
- Stochastic Oscillator
- AVD 70.13
- MIST 90.91
About AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).